Endovascular Treatment for Complex Vascular Pathologies in the Pediatric Population: Experience from a Center with Dual-Trained Neurosurgeons

Endovascular treatment of complex vascular pathologies in the pediatric population is often performed by nonpediatric subspecialists with adaptation of equipment and techniques developed for adult patients. We aimed to report our center's experience with safety and outcomes of endovascular trea...

Full description

Saved in:
Bibliographic Details
Published inWorld neurosurgery Vol. 189; pp. e696 - e708
Main Authors Donnelly, Brianna M., Monteiro, Andre, Recker, Matthew J., Lim, Jaims, Rosalind Lai, Pui Man, Jacoby, Wady T., Khawar, Wasiq I., Becker, Alexander B., Waqas, Muhammad, Cappuzzo, Justin M., Davies, Jason M., Snyder, Kenneth V., Reynolds, Renee M., Siddiqui, Adnan H., Levy, Elad I.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.09.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Endovascular treatment of complex vascular pathologies in the pediatric population is often performed by nonpediatric subspecialists with adaptation of equipment and techniques developed for adult patients. We aimed to report our center's experience with safety and outcomes of endovascular treatments for pediatric vascular pathologies. We performed a retrospective review of our endovascular database. All patients ≤18 years who underwent endovascular treatment between January 1, 2004 and December 1, 2022 were included. During the study time frame, 118 cerebral angiograms were performed for interventional purposes in 55 patients. Of these patients, 8(14.5%) had intracranial aneurysms, 21(38.2%) had intracranial arteriovenous malformations, 6(10.9%) had tumors, 5(9.1%) had arterial occlusions (n = 3) or dissections (n = 2), 8(14.5%) had vein of Galen malformations, and 7(12.7%) had other cerebrovascular conditions. Of the total 118 procedures, access-site complications occurred in 2(1.7%), intraprocedural complications occurred in 3(2.5%), and transient neurological deficits were observed after 2(1.7%). Treatment-related mortality occurred in 1(1.8%) patient. Neurointervention in pediatric patients was safe and effective in our experience.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1878-8750
1878-8769
1878-8769
DOI:10.1016/j.wneu.2024.06.151